IRBESARTAN

NDC 62332-043 · Alembic Pharmaceuticals Inc.

Generic nameIRBESARTAN

Dosage formTABLET

RouteORAL

Active ingredient(s)IRBESARTAN

Strength300 mg/1

Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]

Marketing categoryANDA

Packages

62332-043-30 — 30 TABLET in 1 BOTTLE (62332-043-30)

62332-043-31 — 100 TABLET in 1 BOTTLE (62332-043-31)

62332-043-71 — 500 TABLET in 1 BOTTLE (62332-043-71)

62332-043-90 — 90 TABLET in 1 BOTTLE (62332-043-90)

62332-043-91 — 1000 TABLET in 1 BOTTLE (62332-043-91)

FDA lists these products with the same active ingredient.

50268-441 — Irbesartan, 50268-442 — Irbesartan, 59746-447 — IRBESARTAN, 59746-448 — IRBESARTAN, 59746-449 — IRBESARTAN, 62135-976 — IRBESARTAN, 62135-977 — IRBESARTAN, 62135-978 — IRBESARTAN, 62332-041 — IRBESARTAN, 62332-042 — IRBESARTAN, 62332-051 — Irbesartan and Hydrochlorothiazide, 62332-052 — Irbesartan and Hydrochlorothiazide, 62332-053 — Irbesartan and Hydrochlorothiazide, 63187-653 — Irbesartan and Hydrochlorothiazide, 63187-737 — Irbesartan, 63187-981 — Irbesartan and Hydrochlorothiazide, 63629-5241 — Irbesartan, 63629-7468 — Irbesartan and Hydrochlorothiazide, 63629-8259 — Irbesartan, 65162-284 — Irbesartan, +95 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.